Intel filed to sell $15 billion of common stock on August 10, then upsized the underwritten offering the same day to $20 billion, pricing it at $95 a share. After underwriting discounts, Intel expects net proceeds of about $19.7 billion, which the company says will go toward general corporate purposes, including capital expenditures and working capital, as it expands AI-chip and foundry manufacturing. Shares fell roughly 4% on the announcement — a standard market reaction to dilutive share sales — even after a run that has left the stock up about 175% for 2026 and roughly five times higher than a year ago.
- Jul 2026 — Intel raises its 2026 capital-expenditure guidance to about $20 billion, up from $18 billion, citing stronger AI-compute demand.
- Aug 10, 2026 (morning) — Intel files a $15 billion underwritten common-stock offering.
- Aug 10, 2026 (same day) — Offering upsized to $20 billion, priced at $95/share.
- Aug 10, 2026 — Shares fall about 4% on the announcement.
The same-day upsizing is the detail worth sitting with: Intel didn't plan a $20 billion raise from the start and reveal it gradually — it filed for $15 billion and found enough demand within hours to sell a third more. That kind of order-book strength for a straight equity sale, rather than a convertible or a structured deal, is itself a signal about how investors are currently pricing Intel's AI-driven turnaround, distinct from what the capital will actually be spent on.
What the raise actually covers
Intel's capex guidance, its ask, and its raise are three different figures
- $20B · 2026 capex guidance
- What Intel says it plans to spend this year
Includes: Full-year 2026 capital expenditure across chip manufacturing and foundry buildout, raised from an earlier $18B estimate
Excludes: This stock offering itself — guidance predates it by about a month - $15B · initial offering size
- What Intel first filed to raise
Includes: The original underwritten common-stock offering as filed the morning of August 10
Excludes: The additional amount Intel added when it upsized the offering hours later - $19.7B · expected net proceeds
- What Intel will actually receive
Includes: Gross proceeds from the upsized $20B offering at $95/share, minus underwriting discounts and commissions
Excludes: Any capital Intel raises through debt, government incentives, or other financing this year
Put those three figures side by side and the scale becomes easier to read: a single equity sale, priced and closed in one day, comes close to covering an entire year of the capital spending Intel itself set as its target just a month earlier.
How much of this year's capex does one stock sale cover?
That doesn't mean Intel plans to fund literally all of 2026's spending from this one sale — companies rarely draw down a capital raise against a single year's budget that precisely, and Intel still carries other financing tools, including the CHIPS Act awards and customer prepayments it has drawn on this year. But the proximity of the numbers is a useful gut check on scale: this is not a routine treasury top-up, it is an equity raise sized to materially change how much of Intel's AI buildout is funded by new shareholders versus existing cash flow.
For existing shareholders, the offering is dilutive by roughly 3%, on top of a share price that has already multiplied several times over in 2026 — the kind of dilution investors tend to tolerate more easily after a run like Intel's than they would against a flat or falling stock. The 4% drop on announcement day is consistent with markets pricing in that dilution mechanically rather than reacting to any change in Intel's underlying AI story; the stock's much larger year-to-date gain was untouched by the news.
- Intel announced a $15 billion stock offering August 10, then upsized it to $20 billion the same day.
- The final price was $95 a share, expected to net Intel roughly $19.7 billion.
- Intel raised its 2026 capex guidance to about $20 billion in July, up from $18 billion.
- Proceeds fund AI chip and foundry expansion; Intel stock fell about 4% on the news.
- Caveat: the offering dilutes existing shareholders by roughly 3%, after a stock that has already tripled this year.